Información:
Error:
ID
23638
Descripción
Sandostatin for Patients With Androgen Independent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00510224
Link
https://clinicaltrials.gov/show/NCT00510224
Palabras clave
Versiones (1)
- 10/7/17 10/7/17 -
Subido en
10 de julio de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Prostate Cancer NCT00510224
Eligibility Prostate Cancer NCT00510224
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00510224
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
histologically confirmed adenocarcinoma of the prostate.
boolean
C0007112 (UMLS CUI [1])
ID.2
Item
biochemical disease progression following androgen deprivation and therapy with at least one antiandrogen defined as three rises in psa with psa determinations at least 4 weeks apart and each psa value > 0.2 ng/ml.
boolean
C0279492 (UMLS CUI [1,1])
C1515985 (UMLS CUI [1,2])
C0138741 (UMLS CUI [1,3])
C1515985 (UMLS CUI [1,2])
C0138741 (UMLS CUI [1,3])
ID.3
Item
four weeks since prior therapy with flutamide.
boolean
C0016384 (UMLS CUI [1])
ID.4
Item
six weeks since prior therapy with bicalutamide or nilutamide.
boolean
C0285590 (UMLS CUI [1,1])
C0068771 (UMLS CUI [1,2])
C0068771 (UMLS CUI [1,2])
ID.5
Item
current psa > 5 ng/ml.
boolean
C0201544 (UMLS CUI [1])
ID.6
Item
testosterone <50 ng/dl.
boolean
ID.7
Item
sgpt (alt) < 1.5 times upper limit of normal.
boolean
C0201836 (UMLS CUI [1])
ID.8
Item
fasting blood glucose > 60 mg/dl.
boolean
C0428568 (UMLS CUI [1])
ID.9
Item
ecog performance status 0, 1 or 2.
boolean
ID.10
Item
no visceral or bony metastatic disease (lymph node only metastases are allowed).
boolean
C0027627 (UMLS CUI [1])
ID.11
Item
no prior chemotherapy for prostate cancer.
boolean
C1514457 (UMLS CUI [1])
ID.12
Item
no current treatment with insulin or an oral hypoglycemic.
boolean
C0021641 (UMLS CUI [1,1])
C0359086 (UMLS CUI [1,2])
C0359086 (UMLS CUI [1,2])
ID.13
Item
no history of treatment with octreotide analogs for prostate cancer.
boolean
C0279440 (UMLS CUI [1])
ID.14
Item
no nyha class 3 or 4 cardiac status.
boolean
ID.15
Item
diabetes mellitus requiring medical therapy and/or that which is not controlled by dietary means (hba1c<6.0).
boolean
C0421258 (UMLS CUI [1])
ID.16
Item
a history of gallstones that has been clinically significant. patients who have undergone cholecystectomy are eligible.
boolean
C0008320 (UMLS CUI [1,1])
C1561969 (UMLS CUI [1,2])
C1561969 (UMLS CUI [1,2])
ID.17
Item
other concomitant medical or psychiatric condition which would make it undesirable, in the physician's opinion, for the patient to participate in the protocol or would jeopardize compliance with the protocol requirements.
boolean
C0012634 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,2])
ID.18
Item
prior treatment with chemotherapy for prostate cancer.
boolean
C1514457 (UMLS CUI [1])
ID.19
Item
no current treatment with saw palmetto, or proscar. patients must be off these medicines for more than 4 weeks.
boolean
C0771607 (UMLS CUI [1,1])
C0678149 (UMLS CUI [1,2])
C0678149 (UMLS CUI [1,2])